Ether lipid biosynthesis: Alkyl-dihydroxyacetonephosphate synthase protein deficiency leads to reduced dihydroxyacetonephosphate acyltransferase activities

Journal of Lipid Research

Volumn 40, Issue 11, 1999, Pages 1998-2003

  De Vet, E C J M ^a,d   Ijlst, L ^b   Oostheim, W ^b   Dekker, C ^b   Moser, H W ^c   Van Den Bosch, H ^a   Wanders, R J A ^b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d Genome Campus Hinxton   (United Kingdom)

Author keywords

Peroxisomal disorders; Peroxisomal targeting signal; Peroxisome; Rhizomelic chondrodysplasia punctata

Indexed keywords

COMPLEMENTARY DNA; DIHYDROXYACETONE PHOSPHATE ACYLTRANSFERASE; ETHER LIPID; SYNTHETASE;

AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; CHONDRODYSPLASIA PUNCTATA; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEFICIENCY; FEMALE; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; INFANT; LIPOGENESIS; NEWBORN; PEROXISOME; POINT MUTATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN TARGETING; SIGNAL TRANSDUCTION;

EID: 0032693473     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Horrocks, L. A., and M. Sharma. 1982. Plasmalogens and O-alkyl glycerophospholipids. In Phospholipids. New Comprehensive Biochemistry Vol. 4. J. N. Hawthorne and G. S. Ansell, editors. Amsterdam, Elsevier Biomedical Press. 51-93.
2. Hajra, A. K. 1995. Glycerolipid biosynthesis in peroxisomes (microbodies). Prog. Lipid Res. 34: 343-364.
3. Hajra, A. K., and J. E. Bishop. 1982. Glycerolipid biosynthesis in peroxisomes via the acyl dihydroxyacetone phosphate pathway. Ann. NY Acad. Sci. 386: 170-182.
4. Heymans, H. S. A., R. B. H. Schutgens, R. Tan, H. van den Bosch, and P. Borst. 1983. Severe plasmalogen deficiency in tissues of infants without peroxisomes (Zellweger syndrome). Nature. 306: 69-70.
5. Van den Bosch, H., R. B. H. Schutgens, R. J. A. Wanders, and J. M. Tager. 1992. Biochemistry of peroxisomes. Annu. Rev. Biochem. 61: 157-197.
6. Wanders, R. J. A., P. G. Barth, R. B. H. Schutgens, and H. S. A. Heymans. 1996. Peroxisomal disorders: post- and prenatal diagnosis based on a new classification with flowcharts. Int. Pediatr. 11: 203-214.
7. Motley, A., E. Hettema, B. Distel, and H. Tabak. 1994. Differential protein import deficiencies in human peroxisome assembly disorders. J. Cell Biol. 125: 755-767.
8. Slawecki, M. L., G. Dodt, S. Steinberg, A. B. Moser, H. W. Moser, and S. J. Gould. 1995. Identification of three distinct peroxisomal protein import defects in patients with peroxisome biogenesis disorders. J. Cell Sci. 108: 1817-1829.
9. Swinkels, B. W., S. J. Gould, A. G. Bodnar, R. A. Rachubinski, and S. Subramani. 1991. A novel, cleavable peroxisomal targeting signal at the amino terminus of the rat 3-ketoacyl-CoA thiolase. EMBO J. 10: 3255-3262.
10. Braverman, N., G. Steel, C. Obie, A. Moser, H. Moser, S. J. Gould, and D. Valle. 1997. Human PEX7 encodes the peroxisomal PTS2 receptor and is responsible for rhizomelic chondrodysplasia punctata. Nature Genet. 15: 369-376.
11. Motley, A. M., E. H. Hettema, E. M. Hogenhout, P. Brites, A. L. M. A. ten Asbroek, F. A. Wijburg, F. Baas, H. S. A. Heijmans, H. F. Tabak, R. J. A. Wanders, and B. Distel. 1997. Rhizomelic chondrodysplasia is a peroxisomal targeting disease caused by a non-functional PTS2 receptor. Nature Genet. 15: 377-380.
12. Purdue, P. E., J. W. Zhang, M. Skoneczny, and P. B. Lazarow. 1997. Rhizomelic chondrodysplasia punctata is caused by deficiency of human PEX7, a homologue of the yeast PTS2 receptor. Nature Genet. 15: 381-384.
13. Ofman, R., E. H. Hettema, E. M. Hogenhout, U. Caruso, A. O. Muijsers, and R. J. A. Wanders. 1998. Acyl-CoA:dihydroxyacetonephosphate acyltransferase: cloning of human cDNA and resolution of the molecular basis in rhizomelic chondrodysplasia punctata type 2. Hum. Mol. Genet. 7: 847-853.
14. Wanders, R. J. A., C. Dekker, V. A. P. Horvarth, R. B. H. Schutgens, J. M. Tager, P. van Laer, and D. Lecoutere. 1994. Human alkyldihydroxyacetonephosphate synthase deficiency: a new peroxisomal disorder. J. Inher. Metab. Dis. 17: 315-318.
15. Thai, T-H., H. Heid, H-R. Rackwitz, A. Hunziker, K. Gorgas, and W. W. Just. 1997. Ether lipid synthesis: isolation and molecular characterization of human dihydroxyacetonephosphate acyltransferase. FEBS Lett. 420:205-211.
16. De Vet, E. C. J. M., B. T. E. van den Broek, and H. van den Bosch. 1997. Nucleotide sequence of human alkyl-dihydroxyacetonephosphate synthase cDNA reveals the presence of a peroxisomal targeting signal 2. Biochim. Biophys. Acta. 1346: 25-29.
17. De Vet, E. C. J. M., L. Ijlst, W. Oostheim, R. J. A. Wanders, and H. van den Bosch. 1998. Alkyl-dihydroxyacetonephosphate synthase: fate in peroxisome biogenesis disorders and identification of the point mutation underlying a single enzyme deficiency. J. Biol. Chem. 273: 10296-10301.
18. Jansen, G. A., R. Ofman, S. Ferdinandusse, L. Ijlst, A. O. Muijsers, O. H. Skjeldal, O. Stokke, C. Jakobs, G. T. N. Besley, J. E. Wraith, and R. J. A. Wanders. 1997. Refsum disease is caused by mutations in the phytanoyl-CoA hydroxylase gene. Nature Genet. 17: 190-193.
19. Mihalik, S. J., J. C. Morrell, D. Kim, K. A. Sacksteder, P. A. Watkins, and S. J. Gould. 1997. Identification of PAHX, a Refsum disease gene. Nature genet. 17: 185-189.
20. Hajra, A. K., T. V. Saraswathi, and A. K. Das. 1983. Chemical synthesis of 1-O-alkyl and 1-O-acyl dihydroxyacetone-3-phosphate. Chem. Phys. Lipids. 33: 179-193.
21. Schrakamp, G., C. F. P. Roosenboom, R. B. H. Schutgens, R. J. A. Wanders, H. S. A. Heymans, J. M. Tager, and H. van den Bosch. 1985. Alkyldihydroxyacetonephosphate synthase in human fibroblasts and its deficiency in Zellweger syndrome. J. Lipid Res. 26: 867-873.
22. Schrakamp, G., C. G. Schalkwijk, R. B. H. Schutgens, R. J. A. Wanders, J. M. Tager, and H. van den Bosch. 1988. Plasmalogen biosynthesis in peroxisomal disorders: fatty alcohol versus alkylglycerol precursors. J. Lipid Res. 29: 325-334.
23. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37: 911-917.
24. Schrakamp, G., R. B. H. Schutgens, R. J. A. Wanders, H. S. A. Heymans, J. M. Tager, and H. van den Bosch. 1985. The cerebrohepato-renal (Zellweger) syndrome: Impaired de novo biosynthesis of plasmalogens in cultured skin fibroblast. Biochim. Biophys. Acta. 833: 170-174.
25. Ofman, R., and R. J. A. Wanders. 1994. Purification of peroxisomal acyl-CoA: dihydroxyacetonephosphate acyltransferase from human placenta. Biochim. Biophys. Acta. 1206: 27-34.
26. De Vet, E. C. J. M., J. Biermann, and H. van den Bosch. 1997. Immunological localization and tissue distribution of alkyl-dihydroxyacetonephosphate synthase and deficiency of the enzyme in peroxisomal disorders. Eur. J. Biochem. 247: 511-517.
27. Wanders, R. J. A., C. Dekker, R. Ofman, R. B. H. Schutgens, and P. A. Mooijer. 1995. Immunoblot analysis of peroxisomal proteins in liver and fibroblasts from patients. J. Inher. Metab. Dis. 18 (Suppl. 1): 101-112.
28. Biermann, J., W. W. Just, R. J. A. Wanders, and H. van den Bosch. 1999. Alkyl-dihydroxyacetonephosphate synthase and dihydroxyacetonephosphate acyltransferase form a protein complex in peroxisomes. Eur. J. Biochem. 261: 492-499.
29. Hardeman, D., and H. van den Bosch. 1989. Topography of ether phospholipid biosynthesis. Biochim. Biophys. Acta. 1006: 1-8.
30. Biermann, J., K. Schoonderwoerd, M. L. Hom, L. H. Luthjens, and H. van den Bosch. 1998. The native molecular size of alkyl-dihydroxyacetonephosphate synthase and dihydroxyacetonephosphate acyltransferase. Biochim. Biophys. Acta. 1393: 137-142.